Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. It offers its products under the Allerzine, CartiSafe Forte, Crisbo, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, and Zydol Suspension brand names. The company also exports its products. It serves large government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 458 Cr
P/E 12.80
Div Yield 1.99 %
Book Value βΉ446.00
52w High βΉ1,321.00
52w Low βΉ944.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
35.51
44.63
43.02
45.56
35.53
41.05
36.89
41.22
32.54
38.84
35.66
38.29
29.18
Expenses
29.48
30.38
35.59
32.45
26.58
30.19
28.07
29.79
23.26
28.99
28.47
29.19
22.22
Operating Profit
6.03
14.25
7.43
13.11
8.95
10.86
8.82
11.43
9.28
9.85
7.19
9.10
6.96
OPM %
16.98
31.93
17.27
28.78
25.19
26.46
23.91
27.73
28.52
25.36
20.16
23.77
23.85
Other Income
1.51
0.40
1.82
2.08
2.06
1.88
1.58
1.85
1.41
1.19
1.35
1.10
1.04
Depreciation
0.64
0.81
0.83
0.74
0.72
0.79
0.78
0.64
0.52
0.62
0.63
0.59
0.50
Interest
0.13
0.13
0.12
0.11
0.11
0.11
0.11
0.12
0.11
0.06
0.07
0.07
0.07
Profit before tax
6.77
13.71
8.30
14.34
10.18
11.84
9.51
12.52
10.06
10.36
7.84
9.54
7.43
Tax %
13.00
20.86
28.55
29.08
23.48
27.87
31.65
23.32
26.34
23.94
31.12
23.27
27.73
Net Profit
5.89
10.85
5.93
10.16
7.79
8.54
6.51
9.60
7.42
7.88
5.40
7.32
5.37
EPS in Rs
13.35
24.58
13.44
23.02
17.65
19.35
14.75
21.75
16.81
17.86
12.24
16.59
12.17
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
169.00 152.00 142.00 137.00 124.00 109.00 119.00 123.00 115.00 103.00 94.00 85.00
Expenses
125.00 111.00 109.00 106.00 97.00 89.00 99.00 98.00 91.00 84.00 77.00 70.00
Operating Profit
44.00 40.00 33.00 30.00 27.00 20.00 20.00 25.00 24.00 20.00 16.00 15.00
OPM %
26.00 27.00 23.00 22.00 22.00 18.00 17.00 20.00 21.00 19.00 18.00 18.00
Other Income
6.00 7.00 5.00 5.00 5.00 4.00 4.00 3.00 3.00 3.00 3.00 2.00
Interest
0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00
Depreciation
3.00 3.00 2.00 2.00 2.00 2.00 2.00 1.00 2.00 2.00 2.00 3.00
Profit before tax
47.00 44.00 35.00 33.00 30.00 22.00 21.00 27.00 25.00 20.00 17.00 14.00
Tax %
25.00 27.00 26.00 25.00 25.00 24.00 30.00 26.00 32.00 34.00 36.00 33.00
Net Profit
35.00 32.00 26.00 25.00 22.00 16.00 15.00 20.00 17.00 14.00 11.00 10.00
EPS in Rs
78.72 72.64 58.87 55.76 48.59 35.95 32.40 43.14 37.50 29.06 23.19 20.76
Dividend Payout %
26.00 25.00 26.00 26.00 25.00 28.00 25.00 24.00 24.00 28.00 31.00 30.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
4.00 4.00 4.00 4.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves
193.00 167.00 141.00 118.00 113.00 94.00 75.00 73.00 57.00 50.00 36.00 29.00
Borrowings
2.00 4.00 0.00 3.00 7.00 5.00 3.00 7.00 0.00 6.00 5.00 7.00
Other Liabilities
26.00 19.00 19.00 16.00 18.00 17.00 21.00 18.00 16.00 16.00 12.00 21.00
Total Liabilities
225.00 195.00 164.00 141.00 143.00 120.00 104.00 103.00 77.00 76.00 58.00 61.00
Fixed Assets
19.00 15.00 10.00 10.00 11.00 11.00 12.00 10.00 10.00 11.00 12.00 12.00
CWIP
46.00 40.00 1.00 1.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00
Investments
27.00 21.00 17.00 11.00 8.00 7.00 4.00 5.00 5.00 2.00 1.00 0.00
Other Assets
132.00 120.00 136.00 119.00 123.00 103.00 88.00 87.00 62.00 64.00 45.00 49.00
Total Assets
225.00 195.00 164.00 141.00 143.00 120.00 104.00 103.00 77.00 76.00 58.00 61.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
27.00 28.00 8.00 17.00 9.00 19.00 15.00 13.00 16.00 10.00 8.00 9.00
Cash from Investing Activity
-19.00 -17.00 -1.00 3.00 -1.00 -19.00 -3.00 -11.00 1.00 -10.00 0.00 1.00
Cash from Financing Activity
-9.00 -8.00 -7.00 -21.00 -6.00 -1.00 -11.00 -2.00 -18.00 1.00 -5.00 1.00
Net Cash Flow
-2.00 3.00 0.00 -1.00 3.00 0.00 1.00 0.00 -1.00 1.00 2.00 11.00
Free Cash Flow
13.00 8.00 6.00 15.00 7.00 18.00 11.00 11.00 16.00 10.00 5.00 8.00
CFO/OP %
88.00 102.00 49.00 83.00 62.00 127.00 104.00 80.00 103.00 85.00 82.00 88.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
53.00 50.00 50.00 45.00 45.00 47.00 55.00 68.00 40.00 32.00 23.00 32.00
Inventory Days
154.00 109.00 103.00 92.00 115.00 92.00 120.00 99.00 73.00 128.00 109.00 107.00
Days Payable
91.00 100.00 75.00 67.00 83.00 56.00 58.00 66.00 44.00 72.00 44.00 54.00
Cash Conversion Cycle
115.00 59.00 78.00 70.00 77.00 83.00 117.00 101.00 69.00 89.00 88.00 85.00
Working Capital Days
41.00 31.00 36.00 31.00 16.00 17.00 32.00 35.00 25.00 10.00 6.00 -11.00
ROCE %
27.00 27.00 26.00 27.00 26.00 24.00 26.00 37.00 42.00 39.00 40.00 42.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
46.62
46.64
46.65
46.66
46.67
46.68
46.69
46.71
46.71
47.23
47.39
47.42
FIIs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.38
DIIs
0.12
0.12
0.12
0.12
0.12
0.12
0.12
0.00
0.00
0.00
0.00
0.00
Public
53.27
53.24
53.24
53.22
53.21
53.20
53.20
53.28
53.29
52.78
52.63
51.21
No. of Shareholders
7,103
6,999
7,163
6,855
6,712
6,987
6,901
6,628
6,419
6,316
6,021
5,872
Corporate Actions
23 records
Back to all stocks